Video

Ann Brazeau on the Importance of MPN Support Groups

Author(s):

Ann Brazeau

Ann Brazeau, founder and CEO of MPN Advocacy & Education International and a 2016 MPN Hero, discusses the importance and benefits of MPN support groups.

Ann Brazeau, founder and CEO of MPN Advocacy & Education International and a 2016 MPN Hero, discusses the importance and benefits of MPN support groups.

For patients with myeloproliferative neoplasms, it is essential to know that there is a safe place to share stories with other patients, get educated on their disease and learn about nearby doctors and treatment options. Brazeau mentioned that there is a growing number of researchers and clinicians in the field, and support groups can help match patients with these resources.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of two doctors with text.
image of gerds
Image of 2 doctors and text.
Image of two doctors and text.
Image of man.
Image of thumbnail.
Patients can prepare personal overviews to help care teams connect with them as individuals, explained Michelle Kirschner in an interview with CURE.
Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.
Expanding on a New Way to Manage Polycythemia Vera Without Iron Deficiency
Image of woman.
Related Content
The FDA granted fast track designation to nuvisertib for those with intermediate or high-risk myelofibrosis: © stock.adobe.com.
June 16th 2025

FDA Grants Fast Track Designation to Nuvisertib in Myelofibrosis

Spencer Feldman
The FDA granted fast track designation to nuvisertib for those with intermediate or high-risk myelofibrosis, which demonstrated symptom relief in patients.
Cancer Horizons podcast logo
January 8th 2024

FDA Stops Lung Cancer Trial, CAR-T Cell Therapy Is Cost Effective, Novel Drug Slows Fibrosis

Alex Biese Brielle Benyon
The year 2024 is now underway. After a busy 2023, we’re now looking back at some of the oncology headlines from the new year.
From left: Katherine Mast Hagemann, B.S.N., RN, and Dr. Andrew Kuykendall
June 5th 2025

A Unicorn Among Us

Dr. Andrew Kuykendall
Katherine has an exquisite instinct for understanding that there is a context to each patient’s diagnosis that is just as important to understand.
LeVar Burton Helping the MPN Community Through Advocacy and Storytelling
December 16th 2021

LeVar Burton Helping the MPN Community Through Advocacy and Storytelling

Jamie Cesanek Darlene Dobkowski, MA
On this episode of the “Cancer Horizons” podcast, LeVar Burton sits down with CURE® to talk about the importance of MPN awareness and the power of storytelling in advocacy.
Image of blood cells.
May 21st 2025

Evolving Myelofibrosis Treatments Aims to Fill Unmet Needs

Ryan Scott
JAK inhibitors ease symptoms in myelofibrosis, but only stem cell transplant offers a cure; newer drugs aim to fill unmet needs, especially for anemia.
Dr. Suresh S. Ramalingam explains that patients with stage 3 lung cancer who undergo chemotherapy and radiation may develop radiation pneumonitis.
May 7th 2025

Managing Lung Inflammation After Chemoradiation and Tagrisso

Dr. Suresh S. Ramalingam
Dr. Suresh S. Ramalingam explains that patients with stage 3 lung cancer who undergo chemotherapy and radiation may develop radiation pneumonitis.